REFERENCES
1. Wallace A, Richards GM, Harari PM, Kirwan JM, Morris CG, Katakam H,
et al. Head and neck squamous cell carcinoma from an unknown primary
site. Am J Otolaryngol. 2011 Jul;32(4):286–90.
2. Hobbs CGL, Sterne JAC, Bailey M, Heyderman RS, Birchall MA, Thomas
SJ. Human papillomavirus and head and neck cancer: a systematic review
and meta-analysis. Clin Otolaryngol Off J ENT-UK ; Off J Netherlands
Soc Oto-Rhino-Laryngology Cerv-fac Surg. 2006 Aug;31(4):259–66.
3. Zanoni DK, Patel SG, Shah JP. Changes in the 8th Edition of the
American Joint Committee on Cancer (AJCC) Staging of Head and Neck
Cancer: Rationale and Implications. Curr Oncol Rep. 2019 Apr;21(6):52.
4. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V,
et al. Prevalence of human papillomavirus in oropharyngeal and
nonoropharyngeal head and neck cancer–systematic review and
meta-analysis of trends by time and region. Head Neck. 2013
May;35(5):747–55.
5. Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, et
al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity
adjuvant treatment in patients undergoing transoral surgery for Human
papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015
Aug;15:602.
6. Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, et al.
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity
Modulated Radiation Therapy in Resectable p16+ Locally Advanced
Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J
Clin Oncol Off J Am Soc Clin Oncol. 2021 Oct;JCO2101752.
7. Mackenzie K, Watson M, Jankowska P, Bhide S, Simo R. Investigation
and management of the unknown primary with metastatic neck disease:
United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol.
2016/05/12. 2016;130(S2):S170–5.
8. Maghami E, Ismaila N, Alvarez A, Chernock R, Duvvuri U, Geiger J, et
al. Diagnosis and Management of Squamous Cell Carcinoma of Unknown
Primary in the Head and Neck: ASCO Guideline. J Clin Oncol.
2020;38(22):2570–96.
9. National Comprehensive Cancer Network. NCCN Clinical Practice
Guidelines in Oncology (NCCN Guidelines®): Head and Neck Cancers. 2021.
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis
JPA, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate healthcare interventions:
explanation and elaboration. BMJ. 2009 Jul;339:b2700.
11. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J.
Methodological index for non-randomized studies (minors): development
and validation of a new instrument. ANZ J Surg. 2003 Sep;73(9):712–6.
12. Abu-Shama Y, Salleron J, Carsuzaa F, Sun X-S, Pflumio C, Troussier
I, et al. Impact of Neck Dissection in Head and Neck Squamous Cell
Carcinomas of Unknown Primary. Cancers (Basel). 2021 May;13(10).
13. Cho WK, Roh J-L, Cho K-J, Choi S-H, Nam SY, Kim SY. Predictors of
survival and recurrence after primary surgery for cervical metastasis of
unknown primary. J Cancer Res Clin Oncol. 2020 Apr;146(4):925–33.
14. Dragan AD, Nixon IJ, Guerrero-Urbano MT, Oakley R, Jeannon J-P, Simo
R. Selective neck dissection as a therapeutic option in management of
squamous cell carcinoma of unknown primary. Eur Arch
oto-rhino-laryngology Off J Eur Fed Oto-Rhino-Laryngological Soc Affil
with Ger Soc Oto-Rhino-Laryngology - Head Neck Surg. 2014
May;271(5):1249–56.
15. Eisbruch A, Koukourakis G V, Gutfeld O, Prince ME, Bradford CR, Wolf
GT, et al. Head and neck squamous cell carcinoma of unknown primary:
Neck dissection and radiotherapy or definitive radiotherapy. Head Neck.
2013;
16. Keller LM, Galloway TJ, Holdbrook T, Flieder DB, Ruth K, Lango MN,
et al. P16 Status, pathologic and clinical characteristics, and
long-term outcomes in unknown primary carcinomas of the head and neck.
Int J Radiat Oncol Biol Phys. 2012;84(3 SUPPL. 1):S514.
17. Santa Maria PL, Sader C, Preston NJM, Fisher PH. Neck dissection for
squamous cell carcinoma of the head and neck. Otolaryngol neck Surg Off
J Am Acad Otolaryngol Neck Surg. 2007 Apr;136(4 Suppl):S41-5.
18. Guntinas-Lichius O, Peter Klussmann J, Dinh S, Dinh M, Schmidt M,
Semrau R, et al. Diagnostic work-up and outcome of cervical metastases
from an unknown primary. Acta Otolaryngol. 2006 May;126(5):536–44.
19. Boscolo-Rizzo P, Da Mosto MC, Gava A, Marchiori C. Cervical lymph
node metastases from occult squamous cell carcinoma: analysis of 82
cases. ORL J Otorhinolaryngol Relat Spec. 2006;68(4):189–94.
20. Yalin Y, Pingzhang T, Smith GI, Ilankovan V. Management and outcome
of cervical lymph node metastases of unknown primary sites: a
retrospective study. Br J Oral Maxillofac Surg. 2002 Dec;40(6):484–7.
21. Hatten KM, O’Malley BWJ, Bur AM, Patel MR, Rassekh CH, Newman JG, et
al. Transoral Robotic Surgery-Assisted Endoscopy With Primary Site
Detection and Treatment in Occult Mucosal Primaries. JAMA Otolaryngol
Head Neck Surg. 2017 Mar;143(3):267–73.
22. Al Kadah B, Papaspyrou G, Linxweiler M, Schick B, Rübe C, Büchler
BS, et al. Cancer of unknown primary (CUP) of the head and neck:
retrospective analysis of 81 patients. Eur Arch oto-rhino-laryngology
Off J Eur Fed Oto-Rhino-Laryngological Soc Affil with Ger Soc
Oto-Rhino-Laryngology - Head Neck Surg. 2017 Jun;274(6):2557–66.
23. Amsbaugh MJ, Yusuf M, Gaskins J, Silverman C, Potts K, Bumpous J, et
al. Neck dissection for unknown cancer of the head and neck in the era
of chemoradiation. Am J Otolaryngol. 2017;38(5):588–92.
24. Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, et al.
Five-year outcomes of an oropharynx-directed treatment approach for
unknown primary of the head and neck. Oral Oncol. 2017 Jul;70:14–22.
25. Patel SA, Parvathaneni A, Parvathaneni U, Houlton JJ, Karni RJ, Liao
JJ, et al. Post-operative therapy following transoral robotic surgery
for unknown primary cancers of the head and neck. Oral Oncol. 2017
Sep;72:150–6.
26. Kharytaniuk N, Molony P, Boyle S, O’Leary G, Werner R, Heffron C, et
al. Association of Extracapsular Spread With Survival According to Human
Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and
Carcinoma of Unknown Primary Site. JAMA Otolaryngol Head Neck Surg. 2016
Jul;142(7):683–90.
27. Graboyes EM, Sinha P, Thorstad WL, Rich JT, Haughey BH. Management
of human papillomavirus-related unknown primaries of the head and neck
with a transoral surgical approach. Head Neck. 2015 Nov;37(11):1603–11.
28. Demiroz C, Vainshtein JM, Koukourakis G V, Gutfeld O, Prince ME,
Bradford CR, et al. Head and neck squamous cell carcinoma of unknown
primary: neck dissection and radiotherapy or definitive radiotherapy.
Head Neck. 2014 Nov;36(11):1589–95.
29. Marinov V, Rangachev J, Popov G. Cervical lymph node metastasis from
an unknown primary site. Laryngorhinootologie. 2019;98(Supplement
2):S264–5.
30. Amsbaugh MJ, Perez CA, Gaskins J, Silverman CL, Bumpous J, Potts K,
et al. Squamous cell cancer of an unknown primary head and neck site: Is
upfront neck dissection still relevant in the era of chemoradiation? Int
J Radiat Oncol Biol Phys. 2016;94(4):894.
31. Colbert S, Algholmy M, Gray M, Walji S, Davies J. Management of the
cervical lymph node metastasis of unknown origin. Br J Oral Maxillofac
Surg. 2011;49(SUPPL. 1):S43.
32. Kar A, Eichholz A, Sarkodie T, Simo R, O’Connell MEA. Metastatic
squamous cell carcinoma of head & neck of unknown primaryorig in
treated by neck dissection and pan-mucosal post-operative radiotherapy
(PORT): outcomes, toxicity and prognostic factors. Radiother Oncol.
2010;96:S323‐.
33. Matsuzuka T, Kano M, Sato H, Suzuki M, Ozawa K. Therapy unknown
cervical metastasis from unknown primary sites. Oto-Rhino-Laryngology
Tokyo. 2003;46(SUPPL. 2):62–7.
34. Sato N, Kuwashima S, Sato H, Murai K. Analysis of cervical
metastatic carcinomas from unknown primary tumors. Oto-Rhino-Laryngology
Tokyo. 2003;46(SUPPL. 2):44–8.
35. Kadokura Y, Yanagi Y, Kubota T, Matsui K, Takemura H, Nagase D.
Clinical analysis of metastatic cancer from unknown primary sites. Pract
Otol Suppl. 2002;(109):167–71.
36. Cappello ZJ, Eid M, Cash E, Tennant P, Potts K, Wilson L, et al.
Prognostic indications of p16 and smoking status in predicting the need
for posttreatment neck dissection after chemoradiation therapy in head
and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys.
2016;94(4):908–9.
37. Silva JP, Alexandre MT, Ferreira D, Sargento I, Ferreira M, Moreira
A, et al. Cercival lymph node metastasis of squamous cell carcinoma of
an unknown primary (SCCUP): A single institutional review. Ann Oncol.
2016;27(Supplement 6).
38. Amsbaugh MJ, Silverman CL, Bumpous J, Potts K, Perez C, Bert R, et
al. Upfront neck dissection in the era of chemoradiation for head and
neck squamous cell carcinoma of unknown primary site. Int J Radiat Oncol
Biol Phys. 2015;93(3 SUPPL. 1):E324.
39. Nguyen N, Hodson D, Doerwald-Munoz LE, Jim W, Zhang H. Head and neck
squamous cell carcinoma of unknown primary: Is there a better treatment?
Int J Radiat Oncol Biol Phys. 2014;90(1 SUPPL. 1):S570.
40. Berta E, Reyt E, Atallah I, Righini CA, Quesada JL, Villa J, et al.
Treatmentof head and neck squamous cell carcinoma of an unknown primary
(HNCCUP): Oncologic analysis of 35 cases. Rev Laryngol Otol Rhinol.
2013;134(3):131–8.
41. Kobayashi K, Omura G, Saito Y, Ebihara Y, Asakage T, Yamasoba T.
Prognostic factors in recent head and neck squamous cell carcinoma of
unknown primary site (HNSCCUP). Otolaryngol - Head Neck Surg (United
States). 2013;149(2 SUPPL. 1):P187.
42. Straetmans J, Lacko M, Mujagic Z, Kremer B, Speel E-J, Vent J, et
al. Differenc es in managem ent of neck metastases of unknown primary
origin in two european centres: Conseque nces for future strategies.
Oral Oncol. 2013;49(SUPPL. 1):S54.
43. Simo R, Dragan A, Nixon I, Guerrero-Urbano MT, Oakley R, Jeannon
J-P. Patterns of neck metastases in patients presenting with cervical
squamous cell carcinoma of unknown origin X. Eur Arch
Oto-Rhino-Laryngology. 2012;269(4):1358–9.
44. Lou J, Guo L, Zhao J, Wang S. [Squamous cell carcinoma of cervical
lymph nodes from an unknown primary site: a retrospective analysis of
treatment strategies and prognosis]. Zhonghua er bi yan hou tou jing
wai ke za zhi = Chinese J Otorhinolaryngol head neck Surg. 2013
Jan;48(1):32–6.
45. Tagawa T, Tomita T, Yamaguchi H, Ozawa H, Sakamoto K, Ogawa K, et
al. [Clinical study of 28 cases of cervical lymph node metastasis from
an unknown primary carcinoma]. Nihon Jibiinkoka Gakkai Kaiho. 2007
Jul;110(7):506–12.
46. Ijichi K, Hasegawa Y, Ogawa T, Terada A, Hyodo I, Yamada H, et al.
[Investigation for cervical lymph node metastasis in unknown primary
sites]. Nihon Jibiinkoka Gakkai Kaiho. 2005 Nov;108(11):1083–90.
47. Watanabe F, Yamamoto E, Shiomi Y, Tanabe M, Fujiwara K, Kikuchi M.
Cervical lymph node metastasis from an unknown primary tumor. Pract
Otorhinolaryngol (Basel). 2003;96(4):361–4.
48. Koscielny S, Gudziol H, Kretzschmar J. Cervical lymph nodes of
unknown primary. Laryngorhinootologie. 2000;79(8):483–9.
49. Klop WM, Balm AJ, Keus RB, Hilgers FJ, Tan IB. [Diagnosis and
treatment of 39 patients with cervical lymph node metastases of squamous
cell carcinoma of unknown primary origin, referred to Netherlands Cancer
Institute/Antoni van Leeuwenhoek Hospital, 1979-98]. Ned Tijdschr
Geneeskd. 2000 Jul;144(28):1355–60.
50. Wichmann G, Willner M, Kuhnt T, Kluge R, Gradistanac T, Wald T, et
al. Standardized Diagnostics Including PET-CT Imaging, Bilateral
Tonsillectomy and Neck Dissection Followed by Risk-Adapted
Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of
Neck Squamous Cell Carcinoma of Unknown Primary Patients. Front Oncol.
2021;11:682088.
51. Cummings MA, Ma SJ, Van Der Sloot P, Milano MT, Singh DP, Singh AK.
Squamous cell carcinoma of the head and neck with unknown primary:
trends and outcomes from a hospital-based registry. Ann Transl Med. 2021
Feb;9(4):284.
52. Rödel RMW, Matthias C, Blomeyer BD, Wolff HA, Jung K, Christiansen
H. Impact of distant metastasis in patients with cervical lymph node
metastases from cancer of an unknown primary site. Ann Otol Rhinol
Laryngol. 2009 Sep;118(9):662–9.
53. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA.
Management of the unknown primary carcinoma: long-term follow-up on a
negative PET scan and negative panendoscopy. Head Neck. 2008
Jan;30(1):28–34.
54. Patel RS, Clark J, Wyten R, Gao K, O’Brien CJ. Squamous cell
carcinoma from an unknown head and neck primary site: a “selective
treatment” approach. Arch Otolaryngol Head Neck Surg. 2007
Dec;133(12):1282–7.
55. Iganej S, Kagan R, Anderson P, Rao A, Tome M, Wang R, et al.
Metastatic squamous cell carcinoma of the neck from an unknown primary:
management options and patterns of relapse. Head Neck. 2002
Mar;24(3):236–46.
56. Dorobisz K, Wlodarska-Polinska I, Pazdro-Zastawny K, Rutkowski T,
Palka P, Dworzecki T, et al. The impact of the patient’s condition,
diagnostic procedures and treatment on the survival of carcinoma of
unknown primary site patients. Cancer Manag Res. 2019;11:6603–14.
57. Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, et al.
Squamous cell carcinoma of unknown primary of the head and neck:
Favorable prognostic factors comparable to those in oropharyngeal
cancer. Head Neck. 2018 May;40(5):904–16.
58. Mizuta M, Kitamura M, Tateya I, Tamaki H, Tanaka S, Asato R, et al.
Unknown primary squamous cell carcinoma of the head and neck:
retrospective analysis of 80 cases. Acta Otolaryngol. 2018
Jun;138(6):590–6.
59. Hung Y-H, Liu S-A, Wang C-C, Wang C-P, Jiang R-S, Wu S-H. Treatment
outcomes of unknown primary squamous cell carcinoma of the head and
neck. PLoS One. 2018;13(10):e0205365.
60. Axelsson L, Nyman J, Haugen-Cange H, Bove M, Johansson L, De Lara S,
et al. Prognostic factors for head and neck cancer of unknown primary
including the impact of human papilloma virus infection. J Otolaryngol -
head neck Surg = Le J d’oto-rhino-laryngologie Chir cervico-faciale.
2017 Jun;46(1):45.
61. Dou S, Qian W, Ji Q, Wang Z, Zhu G. Tailored multimodality therapy
guided by a two-step decision making process for head-and-neck cancer of
unknown primary. Oncotarget. 2016 Jun;7(26):40095–105.
62. Lou J, Wang S, Wang K, Chen C, Zhao J, Guo L. Squamous cell
carcinoma of cervical lymph nodes from an unknown primary site: The
impact of neck dissection. J Cancer Res Ther. 2015 Oct;11 Suppl
2:C161-7.
63. Wongsritrang K, Fueangkamloon S. Clinical outcomes of cervical node
metastasis from an unknown primary in Songklanagarind Hospital. J Med
Assoc Thai. 2012 Sep;95(9):1200–4.
64. Axelsson L, Holmberg E, Nyman J, Hogmo A, Sjodin H, Gebre-Medhin M,
et al. Swedish national multicenter study on head and neck cancer of
unknown primary: prognostic factors and impact of treatment on survival.
Int Arch Otorhinolaryngol. 2020;
65. Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal
carcinoma. Lancet (London, England). 2019 Jul;394(10192):64–80.
66. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF,
et al. Human papillomavirus and survival of patients with oropharyngeal
cancer. N Engl J Med. 2010 Jul;363(1):24–35.